Compound class:
Synthetic organic
Comment: Compound 21b is an experimental, selective and irreversible inhibitor of LOXL2 that has an aminomethylenethiazole (AMTz) scaffold [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Compound 21b exhibits potent anti-tumour activity in a mouse model of LOX-driven spontaneous breast cancer development [1]. The IC50 for inhibition of LOXL3 is 1250 nM. Compound 21b does not significantly inhibit other amine oxidase enzymes or the hERG potassium ion channel. |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|